Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

A leading UK eating disorder clinic has issued an urgent warning about the growing dangers of online access to buying weight ...

The Weight Loss Revolution— that’s released on Wednesday provides a detailed insight into these weight management drugs and ...

Weight-loss drugs look poised to have a worrying effect on UK supermarkets as total grocery sales volumes fall. Market ...

In total, there have been 10 deaths linked to the drugs, as Professor Matt Brown, the chief scientific officer of Genomics ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Cardiologists need to embrace the wave of new drugs, say experts, particularly since they can reduce the risk of CVD.

Health officials have launched a new study into the effects of weight loss jabs after hundreds reported bad reactions to the ...